Dr. Lisa Larkin presents a session on the physiological changes of perimenopause and menopause, focusing on weight gain and body composition alterations. The discussion covers the pathophysiology of these transitions and examines the role of menopausal hormone therapy (MHT), including its benefits and risks for women with obesity.

Dr. Larkin explores the latest research on MHT's impact on metabolic parameters, insulin resistance, and lipid profiles, providing evidence-based insights for clinical practice.

Learning Objectives:

• Describe perimenopause and menopause pathophysiology and symptoms

• Analyze menopausal transition's impact on weight and body composition

• Assess menopausal hormone therapy (MHT) benefits and risks